GMI co-founder, Dr. Sean Ennis, was hosted by the Ireland Strategic Investment Fund (ISIF) to join the discussion with other ISIF investment companies at the “Investing in Ireland – 2020 and Beyond” conference held today at the Convention Centre Dublin.
Dr. Kari Stefansson and Dr. Paul Saunders Appointed to the Board
Irish life sciences company Genomics Medicine Ireland Ltd., has today announced the appointment of Dr. Kari Stefansson and Dr. Paul Saunders to its Board of Directors. The appointment will increase the size of the Genomics Medicine Ireland Board of Directors to six members. Read More
Genomics Medicine Ireland was featured in Silicon Republic’s 25 Interesting European AI start-ups to watch in 2017 as one of the Irish companies carrying the torch for this technology revolution.
Genomic information from thousands of people in Ireland may unearth new clues in the hunt for markers of disease and new medicines to treat them.
Read the recent interview with GMI co-founder, Dr. Sean Ennis, on AbbVie’s website.
GMI joins the battle to beat rare disorders in conjunction with Temple Street Hospital with our new study which kicked off yesterday. This issue was highlighted on The Pat Kenny Show yesterday morning featuring Professor Mary King and Angelina Ryan who is the mother of baby Ava whose life was cut short by a rare epilepsy. Listen in to the highlights from the programme to learn more.
Study Will Employ Advanced Technology to Explore Genetic Factors In Rare Conditions
Dublin, 28th February, 2017: Irish life-sciences company, Genomics Medicine Ireland Ltd. (GMI) has partnered with Temple Street Children’s University Hospital and the UCD Academic Centre on Rare Diseases (ACoRD) to launch a groundbreaking research study which will examine children with rare undiagnosed genetic disorders attending Temple Street, and their parents in order to identify the key genetic components of rare disorders. The study will combine advanced scientific technology in genomics, the study of all of a person’s genes, together with detailed clinical information to identify the genetic cause of rare disorders affecting/amongst families in Ireland. Read More